Effects of Catecholamines on the Immune Response

NeuroImmune Biology

Volumn 7, Issue C, 2007, Pages 189-206

  Elenkov, Ilia J ^a  

^a CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957097548     PISSN: 15677443     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-7443(07)00210-4     Document Type: Review

References (119)

1. Besedovsky H.O., del Rey A.E., and Sorkin E. What do the immune system and the brain know about each other?. Immunol Today 4 (1983) 342-346
2. Chrousos G.P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332 20 (1995) 1351-1362
3. Elenkov I.J., Wilder R.L., Chrousos G.P., and Vizi E.S. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52 4 (2000) 595-638
4. Elenkov I.J., Iezzoni D.J., Daly A., Harris A.J., and Chrousos G.P. Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 12 (2005) 255-269
5. Rook G.A., Hernandez-Pando R., and Lightman S.L. Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. Immunol Today 15 7 (1994) 301-303
6. Elenkov I.J., and Chrousos G.P. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol Metab 10 9 (1999) 359-368
7. Marshall Jr. G.D., and Agarwal S.K. Stress, immune regulation, and immunity: applications for asthma. Allergy Asthma Proc 21 4 (2000) 241-246
8. Rook G.A., Lightman S.L., and Heijnen C.J. Can nerve damage disrupt neuroendocrine immune homeostasis? Leprosy as a case in point. Trends Immunol 23 1 (2002) 18-22
9. Tonkoff W. Zur Kenntnis der Nerven der Lymphdrüsen. Anat Anz 16 (1899) 456-459
10. Benschop R.J., Rodriguez-Feuerhahn M., and Schedlowski M. Catecholamine-induced leukocytosis: early observations, current research, and future directions. Brain Behav Immun 10 2 (1996) 77-91
11. von Euler U.S. The presence of a substance with sympathin E properties in spleen extracts. Acta Physiol Scand 11 (1946) 168-173
12. Dougherty T.F., and Frank J.A. The quantitative and qualitative responses of blood lymphocytes to stress stimuli. J Lab Clin Med 42 (1953) 530-537
13. Besedovsky H., Sorkin E., Keller M., and Muller J. Changes in blood hormone levels during the immune response. Proc Soc Exp Biol Med 150 2 (1975) 466-470
14. Besedovsky H., Del Rey A., Sorkin E., and Dinarello C.A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233 4764 (1986) 652-654
15. Besedovsky H., Del Rey A., Sorkin E., Da Prada M., Burri R., and Honegger C. The immune response evokes changes in brain noradrenergic neurons. Science 221 4610 (1983) 564-566
16. Besedovsky H.O., del R.A., Sorkin E., Da P.M., and Keller H.H. Immunoregulation mediated by the sympathetic nervous system. Cell Immunol 48 2 (1979) 346-355
17. Hadden J.W., Hadden E.M., and Middleton Jr. E. Lymphocyte blast transformation I. Demonstration of adrenergic receptors in human peripheral lymphocytes. Cell Immunol 1 (1970) 583-595
18. Reilly F.D., McCuskey R.S., and Meineke H.A. Studies of the hemopoietic microenvironment. VIII. Andrenergic and cholinergic innervation of the murine spleen. Anat Rec 185 (1976) 109-117
19. Williams J.M., and Felten D.L. Sympathetic innervation of murine thymus and spleen: a comparative histofluorescence study. Anat Rec 199 (1981) 531-542
20. Felten D.L., Felten S.Y., Carlson S.L., Olschowka J.A., and Livnat S. Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol 135 2 Suppl (1985) 755s-765s
21. Williams J.M., and Felten D.L. Sympathetic innervation of murine thymus and spleen: a comparative histofluorescence study. Anat Rec 199 4 (1981) 531-542
22. Vizi E.S., Orso E., Osipenko O.N., Hasko G., and Elenkov I.J. Neurochemical, electrophysiological and immunocytochemical evidence for a noradrenergic link between the sympathetic nervous system and thymocytes. Neuroscience 68 4 (1995) 1263-1276
23. Weihe E., Nohr D., Michel S., Muller S., Zentel H.J., Fink T., et al. Molecular anatomy of the neuro-immune connection. Int J Neurosci 59 (1991) 1-23
24. Weihe E., Muller S., Fink T., and Zentel H.J. Tachykinins, calcitonin gene-related peptide and neuropeptide Y in nerves of the mammalian thymus: interactions with mast cells in autonomic and sensory neuroimmunomodulation?. Neurosci Lett 100 (1989) 77-82
25. Schedlowski M., Hosch W., Oberbeck R., Benschop R.J., Jacobs R., Raab H.R., et al. Catecholamines modulate human NK cell circulation and function via spleen-independent beta 2-adrenergic mechanisms. J Immunol 156 1 (1996) 93-99
26. Maisel A.S., and Michel M.C. Beta-adrenoceptor control of immune function in congestive heart failure. Br J Clin Pharmacol 30 Suppl 1 (1990) 49S-53S
27. Knudsen J.H., Christensen N.J., and Bratholm P. Lymphocyte norepinephrine and epinephrine, but not plasma catecholamines predict lymphocyte cAMP production. Life Sci 59 8 (1996) 639-647
28. Chambers D.A., Cohen R.L., and Perlman R.L. Neuroimmune modulation: signal transduction and catecholamines. Neurochem Int 22 2 (1993) 95-110
29. Elliott L., Brooks W., and Roszman T. Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation by dexamethasone, isoproterenol, or prostaglandin E2 either alone or in combination. Cell Mol Neurobiol 12 5 (1992) 411-427
30. Bartik M.M., Bauman G.P., Brooks W.H., and Roszman T.L. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells. Cell Immunol 158 1 (1994) 116-130
31. Carlson S.L., Brooks W.H., and Roszman T.L. Neurotransmitter-lymphocyte interactions: dual receptor modulation of lymphocyte proliferation and cAMP production. J Neuroimmunol 24 1-2 (1989) 155-162
32. Soliven B., and Nelson D.J. Beta-adrenergic modulation of K+ current in human T lymphocytes. J Membr Biol 117 3 (1990) 263-274
33. Mosmann T.R., and Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17 3 (1996) 138-146
34. Fearon D.T., and Locksley R.M. The instructive role of innate immunity in the acquired immune response. Science 272 5258 (1996) 50-53
35. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3 2 (2003) 133-146
36. Elenkov I.J., Papanicolaou D.A., Wilder R.L., and Chrousos G.P. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc Assoc Am Physicians 108 5 (1996) 374-381
37. Panina-Bordignon P., Mazzeo D., Lucia P.D., D'Ambrosio D., Lang R., Fabbri L., et al. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest 100 6 (1997) 1513-1519
38. Hasko G., Szabo C., Nemeth Z.H., Salzman A.L., and Vizi E.S. Stimulation of beta-adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice. J Neuroimmunol 88 1-2 (1998) 57-61
39. Hetier E., Ayala J., Bousseau A., and Prochiantz A. Modulation of interleukin-1 and tumor necrosis factor expression by beta-adrenergic agonists in mouse ameboid microglial cells. Exp Brain Res 86 (1991) 407-413
40. Severn A., Rapson N.T., Hunter C.A., and Liew F.Y. Regulation of tumor necrosis factor production by adrenaline and β-adrenergic agonists. J Immunol 148 (1992) 3441-3445
41. Nakamura A., Johns E.J., Imaizumi A., Abe T., and Kohsaka T. Regulation of tumour necrosis factor and interleukin-6 gene transcription by beta2-adrenoceptor in the rat astrocytes. J Neuroimmunol 88 (1998) 144-153
42. Koff W.C., Fann A.V., Dunegan M.A., and Lachman L.B. Catecholamine-induced suppression of interleukin-1 production. Lymphokine Res 5 (1986) 239-247
43. van der Poll T., and Lowry S.F. Epinephrine inhibits endotoxin-induced IL-1 beta production: roles of tumor necrosis factor-alpha and IL-10. Am J Physiol 273 6 Pt 2 (1997) R1885-R1890
44. van der Poll T., Coyle S.M., Barbosa K., Braxton C.C., and Lowry S.F. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 97 3 (1996) 713-719
45. Norris J.G., and Benveniste E.N. Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine. J Neuroimmunol 45 (1993) 137-145
46. Maimone D., Cioni C., Rosa S., Macchia G., Aloisi F., and Annunziata P. Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: synergism with IL-1 beta and TNF alpha. J Neuroimmunol 47 (1993) 73-81
47. Sanders V.M., Baker R.A., Ramer-Quinn D.S., Kasprowicz D.J., Fuchs B.A., and Street N.E. Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J Immunol 158 9 (1997) 4200-4210
48. Borger P., Hoekstra Y., Esselink M.T., Postma D.S., Zaagsma J., Vellenga E., et al. Beta-adrenoceptor-mediated inhibition of IFN-gamma, IL-3, and GM-CSF mRNA accumulation in activated human T lymphocytes is solely mediated by the beta2-adrenoceptor subtype. Am J Respir Cell Mol Biol 19 3 (1998) 400-407
49. Elenkov I.J., Hasko G., Kovacs K.J., and Vizi E.S. Modulation of lipopolysaccharide-induced tumor necrosis factor-α production by selective α- and β-adrenergic drugs in mice. J Neuroimmunol 61 2 (1995) 123-131
50. Hasko G., Szabo C., Nemeth Z.H., Salzman A.L., and Vizi E.S. Stimulation of beta-adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice. J Neuroimmunol 88 (1998) 57-61
51. Woiciechowsky C., Asadullah K., Nestler D., Eberhardt B., Platzer C., Schoning B., et al. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med 4 7 (1998) 808-813
52. Le Tulzo Y., Shenkar R., Kaneko D., Moine P., Fantuzzi G., Dinarello C.A., et al. Hemorrhage increases cytokine expression in lung mononuclear cells in mice: involvement of catecholamines in nuclear factor-kappaB regulation and cytokine expression. J Clin Invest 99 7 (1997) 1516-1524
53. Broug-Holub E., Persoons J.H., Schornagel K., Mastbergen S.C., and Kraal G. Effects of stress on alveolar macrophages: a role for the sympathetic nervous system. Am J Respir Cell Mol Biol 19 5 (1998) 842-848
54. Mohamed-Ali V., Flower L., Sethi J., Hotamisligil G., Gray R., Humphries S.E., et al. Beta-Adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies. J Clin Endocrinol Metab 86 12 (2001) 5864-5869
55. Baumann H., and Gauldie J. The acute phase response. Immunol Today 15 2 (1994) 74-80
56. Murray D.R., Prabhu S.D., and Chandrasekar B. Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation 101 20 (2000) 2338-2341
57. Kavelaars A., van de Pol M., Zijlstra J., and Heijnen C.J. Beta 2-adrenergic activation enhances interleukin-8 production by human monocytes. J Neuroimmunol 77 2 (1997) 211-216
58. Linden A. Increased interleukin-8 release by beta-adrenoceptor activation in human transformed bronchial epithelial cells. Br J Pharmacol 119 2 (1996) 402-406
59. Engstad C.S., Lund T., and Osterud B. Epinephrine promotes IL-8 production in human leukocytes via an effect on platelets. Thromb Haemost 81 1 (1999) 139-145
60. Kaplanski G., Porat R., Aiura K., Erban J.K., Gelfand J.A., and Dinarello C.A. Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. Blood 81 10 (1993) 2492-2495
61. Hasko G., Shanley T.P., Egnaczyk G., Nemeth Z.H., Salzman A.L., Vizi E.S., et al. Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1α via a β adrenoceptor mediated mechanism. Br J Pharmacol 125 (1998) 1297-1303
62. Hellstrand K., and Hermodsson S. An immunopharmacological analysis of adrenaline-induced suppression of human natural killer cell cytotoxicity. Int Arch Allergy Appl Immunol 89 (1989) 334-341
63. Whalen M.M., and Bankhurst A.D. Effects of beta-adrenergic receptor activation, cholera toxin and forskolin on human natural killer cell function. Biochem J 272 (1990) 327-331
64. Shakhar G., and Ben-Eliyahu S. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J Immunol 160 7 (1998) 3251-3258
65. Katafuchi T., Take S., and Hori T. Roles of sympathetic nervous system in the suppression of cytotoxicity of splenic natural killer cells in the rat. J Physiol (Lond) 465 (1993) 343-357
66. Irwin M., Hauger R., and Brown M. Central corticotropin-releasing hormone activates the sympathetic nervous system and reduces immune function: increased responsivity of the aged rat. Endocrinology 131 (1992) 1047-1053
67. Irwin M. Stress-induced immune suppression: role of brain corticotropin releasing hormone and autonomic nervous system mechanisms. Adv Neuroimmunol 4 (1994) 29-47
68. Strausbaugh H., and Irwin M. Central corticotropin-releasing hormone reduces cellular immunity. Brain Behav Immun 6 (1992) 11-17
69. Vredevoe D.L., Moser D.K., Gan X.H., and Bonavida B. Natural killer cell anergy to cytokine stimulants in a subgroup of patients with heart failure: relationship to norepinephrine. Neuroimmunomodulation 2 1 (1995) 16-24
70. Koff W.C., and Dunegan M.A. Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones. J Immunol 135 1 (1985) 350-354
71. Koff W.C., and Dunegan M.A. Neuroendocrine hormones suppress macrophage-mediated lysis of herpes simplex virus-infected cells. J Immunol 136 2 (1986) 705-709
72. Bermudez L.E., Wu M., and Young L.S. Effect of stress-related hormones on macrophage receptors and response to tumor necrosis factor. Lymphokine Res 9 (1990) 137-145
73. Chou R.C., Stinson M.W., Noble B.K., and Spengler R.N. Beta-adrenergic receptor regulation of macrophage-derived tumor necrosis factor-alpha production from rats with experimental arthritis. J Neuroimmunol 67 1 (1996) 7-16
74. Suberville S., Bellocq A., Fouqueray B., Philippe C., Lantz O., Perez J., et al. Regulation of interleukin-10 production by beta-adrenergic agonists. Eur J Immunol 26 (1996) 2601-2605
75. Miles B.A., Lafuse W.P., and Zwilling B.S. Binding of alpha-adrenergic receptors stimulates the anti-mycobacterial activity of murine peritoneal macrophages. J Neuroimmunol 71 (1996) 19-24
76. Spengler R.N., Allen R.M., Remick D.G., Strieter R.M., and Kunkel S.L. Stimulation of α-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J Immunol 145 (1990) 1430-1434
77. Baker A.J., and Fuller R.W. Loss of response to beta-adrenoceptor agonists during the maturation of human monocytes to macrophages in vitro. J Leukoc Biol 57 3 (1995) 395-400
78. Chou R.C., Dong X.L., Noble B.K., Knight P.R., and Spengler R.N. Adrenergic regulation of macrophage-derived tumor necrosis factor-alpha generation during a chronic polyarthritis pain model. J Neuroimmunol 82 (1998) 140-148
79. Ignatowski T.A., Gallant S., and Spengler R.N. Temporal regulation by adrenergic receptor stimulation of macrophage (M phi)-derived tumor necrosis factor (TNF) production post-LPS challenge. J Neuroimmunol 65 (1996) 107-117
80. Foreman J.C. Substance P and calcitonin gene-related peptide: effects on mast cells and in human skin. Int Arch Allergy Appl Immunol 82 (1987) 366-371
81. Church M.K., Lowman M.A., Robinson C., Holgate S.T., and Benyon R.C. Interaction of neuropeptides with human mast cells. Int Arch Allergy Appl Immunol 88 (1989) 70-78
82. Theoharides T.C., Spanos C., Pang X., Alferes L., Ligris K., Letourneau R., et al. Stress-induced intracranial mast cell degranulation: a corticotropin-releasing hormone-mediated effect. Endocrinology 136 12 (1995) 5745-5750
83. Theoharides T.C., Singh L.K., Boucher W., Pang X., Letourneau R., Webster E., et al. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 139 1 (1998) 403-413
84. Lotz M., Vaughan J.H., and Carson D.A. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 241 (1988) 1218-1221
85. Kincy-Cain T., and Bost K.L. Substance P-induced IL-12 production by murine macrophages. J Immunol 158 (1997) 2334-2339
86. Ho W.Z., Stavropoulos G., Lai J.P., Hu B.F., Magafa V., Anagnostides S., et al. Substance P C-terminal octapeptide analogues augment tumor necrosis factor-alpha release by human blood monocytes and macrophages. J Neuroimmunol 82 (1998) 126-132
87. Straub R.H., and Cutolo M. Involvement of the hypothalamic - pituitary - adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role. Arthritis Rheum 44 3 (2001) 493-507
88. Cook-Mills J.M., Mokyr M.B., Cohen R.L., Perlman R.L., and Chambers D.A. Neurotransmitter suppression of the in vitro generation of a cytotoxic T lymphocyte response against the syngeneic MOPC-315 plasmacytoma. Cancer Immunol Immunother 40 (1995) 79-87
89. Bender B.S., Bell W.E., Taylor S., and Scarpace P.J. Decreased sensitivity to cAMP in the in vitro generation of memory splenic cytotoxic T-lymphocytes from aged mice: role of phosphodiesterase. J Pharmacol Exp Ther 264 (1993) 1381-1386
90. Hatfield S.M., Petersen B.H., and DiMicco J.A. Beta adrenoceptor modulation of the generation of murine cytotoxic T lymphocytes in vitro. J Pharmacol Exp Ther 239 2 (1986) 460-466
91. Sanders V.M., and Munson A.E. Norepinephrine and the antibody response. Pharmacol Rev 37 (1985) 229-248
92. Coqueret O., Dugas B., Mencia-Huerta J.M., and Braquet P. Regulation of IgE production from human mononuclear cells by beta 2-adrenoceptor agonists [see comments]. Clin Exp Allergy 25 4 (1995) 304-311
93. Coqueret O., Lagente V., Frere C.P., Braquet P., and Mencia-Huerta J.M. Regulation of IgE production by beta 2-adrenoceptor agonists. Ann N Y Acad Sci 725 (1994) 44-49
94. Maestroni G.J. Is hematopoiesis under the influence of neural and neuroendocrine mechanisms?. Histol Histopathol 13 (1998) 271-274
95. Maestroni G.J. Catecholaminergic regulation of hematopoiesis in mice [letter; comment]. Blood 92 (1998) 2971-2973
96. Cavallotti D., Artico M., Iannetti G., and Cavallotti C. Occurrence of adrenergic nerve fibers in human thymus during immune response. Neurochem Int 40 3 (2002) 211-221
97. Dunn A.J. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone. Life Sci 43 5 (1988) 429-435
98. Lerner B.H. Can stress cause disease? Revisiting the tuberculosis research of Thomas Holmes, 1949-1961. Ann Intern Med 124 7 (1996) 673-680
99. Levenstein S., Ackerman S., Kiecolt-Glaser J.K., and Dubois A. Stress and peptic ulcer disease. JAMA 281 1 (1999) 10-11
100. Cohen S., Tyrrell D.A., and Smith A.P. Psychological stress and susceptibility to the common cold [see comments]. N Engl J Med 325 9 (1991) 606-612
101. Padgett D.A., Sheridan J.F., Dorne J., Berntson G.G., Candelora J., and Glaser R. Social stress and the reactivation of latent herpes simplex virus type 1. Proc Natl Acad Sci USA 95 12 (1998) 7231-7235
102. Sainz B., Loutsch J.M., Marquart M.E., and Hill J.M. Stress-associated immunomodulation and herpes simplex virus infections. Med Hypotheses 56 3 (2001) 348-356
103. Cole S.W., Korin Y.D., Fahey J.L., and Zack J.A. Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J Immunol 161 2 (1998) 610-616
104. Cole S.W., Naliboff B.D., Kemeny M.E., Griswold M.P., Fahey J.L., and Zack J.A. Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc Natl Acad Sci USA 98 22 (2001) 12695-12700
105. O'Sullivan S.T., Lederer J.A., Horgan A.F., Chin D.H., Mannick J.A., and Rodrick M.L. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. [see comments]. Ann Surg 222 4 (1995) 482-490
106. Elenkov I.J., Chrousos G.P., and Wilder R.L. Neuroendocrine regulation of IL-12 and TNF-alpha/IL-10 balance. Clinical implications. Ann N Y Acad Sci 917 (2000) 94-105
107. Munford R.S., and Tracey K.J. Is severe sepsis a neuroendocrine disease. Mol Med 8 8 (2002) 437-442
108. Prass K., Meisel C., Hoflich C., Braun J., Halle E., Wolf T., et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation: Reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 198 5 (2003) 725-736
109. Wilder R.L. Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 13 (1995) 307-338
110. Miller L.E., Justen H.P., Scholmerich J., and Straub R.H. The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J 14 13 (2000) 2097-2107
111. Elenkov I.J., Wilder R.L., Bakalov V.K., Link A.A., Dimitrov M.A., Fisher S., et al. IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab 86 10 (2001) 4933-4938
112. Calcagni E., and Elenkov I.J. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann N Y Acad Sci 1069 (2006) 62-76
113. Barnes P., FitzGerald G., Brown M., and Dollery C. Nocturnal asthma and changes in circulating epinephrine, histamine, and cortisol. N Engl J Med 303 5 (1980) 263-267
114. Colombo M.P., Vagliani M., Spreafico F., Parenza M., Chiodoni C., Melani C., et al. Amount of interleukin 12 available at the tumor site is critical for tumor regression. Cancer Res 56 11 (1996) 2531-2534
115. Chouaib S., Asselin-Paturel C., Mami-Chouaib F., Caignard A., and Blay J.Y. The host-tumor immune conflict: from immunosuppression to resistance and destruction. Immunol Today 18 10 (1997) 493-497
116. Shakhar G., and Ben-Eliyahu S. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J Immunol 160 (1998) 3251-3258
117. Li T., Harada M., Tamada K., Abe K., and Nomoto K. Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4+ T cells. Anticancer Res 17 6D (1997) 4259-4268
118. Blay J., White T.D., and Hoskin D.W. The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine. Cancer Res 57 13 (1997) 2602-2605
119. Hoskin D.W., Reynolds T., and Blay J. Adenosine as a possible inhibitor of killer T-cell activation in the microenvironment of solid tumours. Int J Cancer 59 6 (1994) 854-855